Discovery and Characterization of Sialic Acid O-acetylation in Group B Streptococcus

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Jul 21

PMID 15263085

Citations 82

Authors

Amanda L Lewis

Victor Nizet

Ajit Varki

Affiliations

Soon will be listed here.

Abstract

Group B Streptococcus (GBS) is the leading cause of human neonatal sepsis and meningitis. The GBS capsular polysaccharide is a major virulence factor and the active principle of vaccines in phase II trials. All GBS capsules have a terminal alpha 2-3-linked sialic acid [N-acetylneuraminic acid (Neu5Ac)], which interferes with complement-mediated killing. We show here that some of the Neu5Ac residues of the GBS type III capsule are O-acetylated at carbon position 7, 8, or 9, a major modification evidently missed in previous studies. Data are consistent with initial O-acetylation at position 7, and subsequent migration of the O-acetyl ester at positions 8 and 9. O-acetylation was also present on several other GBS serotypes (Ia, Ib, II, V, and VI). Deletion of the CMP-Neu5Ac synthase gene neuA by precise, in-frame allelic replacement gave intracellular accumulation of O-acetylated Neu5Ac, whereas overexpression markedly decreased O-acetylation. Given the known GBS Neu5Ac biosynthesis pathway, these data indicate that O-acetylation occurs on free Neu5Ac, competing with the CMP-Neu5Ac synthase. O-acetylation often generates immunogenic epitopes on bacterial capsular polysaccharides and can modulate human alternate pathway complement activation. Thus, our discovery has important implications for GBS pathogenicity, immunogenicity, and vaccine design.

Citing Articles

Virulence and pathogenicity of group B : Virulence factors and their roles in perinatal infection.

Megli C, Carlin S, Giacobe E, Hillebrand G, Hooven T Virulence. 2025; 16(1):2451173.

PMID: 39844743 PMC: 11758947. DOI: 10.1080/21505594.2025.2451173.

Surface-Controlled Sialoside-Based Biosensing of Viral and Bacterial Neuraminidases.

Alshanski I, Toraskar S, Gordon-Levitan D, Massetti M, Jain P, Vaccaro L Langmuir. 2024; 40(14):7471-7478.

PMID: 38554266 PMC: 11008233. DOI: 10.1021/acs.langmuir.3c03943.

Effect of Side-Chain Functional Groups in the Immunogenicity of Bacterial Surface Glycans.

Tian G, Qin C, Hu J, Zou X, Yin J Molecules. 2023; 28(20).

PMID: 37894591 PMC: 10609480. DOI: 10.3390/molecules28207112.

Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics.

Mastrangeli R, Satwekar A, Bierau H Molecules. 2023; 28(8).

PMID: 37110538 PMC: 10143042. DOI: 10.3390/molecules28083304.

Biocatalysis versus Molecular Recognition in Sialoside-Selective Neuraminidase Biosensing.

Alshanski I, Toraskar S, Shitrit A, Gordon-Levitan D, Jain P, Kikkeri R ACS Chem Biol. 2023; 18(3):605-614.

PMID: 36792550 PMC: 10028605. DOI: 10.1021/acschembio.2c00913.

References

Schrag S, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L . Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342(1):15-20. DOI: 10.1056/NEJM200001063420103. View

Deng L, Kasper D, Krick T, Wessels M . Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J Biol Chem. 2000; 275(11):7497-504. DOI: 10.1074/jbc.275.11.7497. View

Pal S, Chatterjee M, Bhattacharya D, Bandhyopadhyay S, Mandal C . Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology. 2000; 10(6):539-49. DOI: 10.1093/glycob/10.6.539. View

Chaffin D, Beres S, Yim H, Rubens C . The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol. 2000; 182(16):4466-77. PMC: 94618. DOI: 10.1128/JB.182.16.4466-4477.2000. View

ORSKOV F, ORSKOV I, Sutton A, Schneerson R, Lin W, Egan W . Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med. 1979; 149(3):669-85. PMC: 2184817. DOI: 10.1084/jem.149.3.669. View

Glode M, Lewin E, Sutton A, Le C, Gotschlich E, Robbins J . Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J Infect Dis. 1979; 139(1):52-9. DOI: 10.1093/infdis/139.1.52. View

Jennings H, Rosell K, Kasper D . Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can J Biochem. 1980; 58(2):112-20. DOI: 10.1139/o80-016. View

Jennings H, Rosell K, Kasper D . Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus. Proc Natl Acad Sci U S A. 1980; 77(5):2931-5. PMC: 349520. DOI: 10.1073/pnas.77.5.2931. View

Varki A, Kornfeld S . An autosomal dominant gene regulates the extent of 9-O-acetylation of murine erythrocyte sialic acids. A probable explanation for the variation in capacity to activate the human alternate complement pathway. J Exp Med. 1980; 152(3):532-44. PMC: 2185929. DOI: 10.1084/jem.152.3.532. View

10.

Steinhoff M, Lewin E, Gotschlich E, Robbins J . Group C Neisseria meningitidis variant polysaccharide vaccines in children. Infect Immun. 1981; 34(1):144-6. PMC: 350834. DOI: 10.1128/iai.34.1.144-146.1981. View

11.

Jennings H, Rosell K, Katzenellenbogen E, Kasper D . Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J Biol Chem. 1983; 258(3):1793-8. View

12.

Jennings H, Katzenellenbogen E, Lugowski C, Kasper D . Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry. 1983; 22(5):1258-64. DOI: 10.1021/bi00274a042. View

13.

Varki A, Diaz S . A neuraminidase from Streptococcus sanguis that can release O-acetylated sialic acids. J Biol Chem. 1983; 258(20):12465-71. View

14.

Scudder P, Hanfland P, Uemura K, Feizi T . Endo-beta-D-galactosidases of Bacteroides fragilis and Escherichia freundii hydrolyze linear but not branched oligosaccharide domains of glycolipids of the neolacto series. J Biol Chem. 1984; 259(10):6586-92. View

15.

Varki A, Diaz S . The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups. Anal Biochem. 1984; 137(1):236-47. DOI: 10.1016/0003-2697(84)90377-4. View

16.

Kamerling J, Schauer R, Shukla A, Stoll S, van Halbeek H, Vliegenthart J . Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur J Biochem. 1987; 162(3):601-7. DOI: 10.1111/j.1432-1033.1987.tb10681.x. View

17.

Wessels M, Pozsgay V, Kasper D, Jennings H . Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem. 1987; 262(17):8262-7. View

18.

Rubens C, Wessels M, Heggen L, Kasper D . Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987; 84(20):7208-12. PMC: 299259. DOI: 10.1073/pnas.84.20.7208. View

19.

HIGA H, Varki A . Acetyl-coenzyme A:polysialic acid O-acetyltransferase from K1-positive Escherichia coli. The enzyme responsible for the O-acetyl plus phenotype and for O-acetyl form variation. J Biol Chem. 1988; 263(18):8872-8. View

20.

HIGA H, Butor C, Diaz S, Varki A . O-acetylation and de-O-acetylation of sialic acids. O-acetylation of sialic acids in the rat liver Golgi apparatus involves an acetyl intermediate and essential histidine and lysine residues--a transmembrane reaction?. J Biol Chem. 1989; 264(32):19427-34. View